Evidence map›Paper›PMID 39982973›Full record

ArticlePLOS global public health2025

Perceptions and predictors of COVID-19 vaccine hesitancy among healthcare providers across five countries in sub-Saharan Africa.

Isabel Madzorera, Livesy Naafoe Abokyi, Edward Apraku, Temesgen Azemraw, Valentin Boudo, Christabel James, Dongqing Wang, Frank Mapendo, Ourohiré Millogo, Nega Assefa and 18 more

Abstract read
In one paragraph

Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Isabel MadzoreraDivision of Community Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, California, United States of America.ORCID https://orcid.org/0000-0001-7226-5997
Livesy Naafoe AbokyiKintampo Health Research Center, Research and Development Division, Ghana Health Service, Kintampo, Ghana.
Edward AprakuKintampo Health Research Center, Research and Development Division, Ghana Health Service, Kintampo, Ghana.
Temesgen AzemrawCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Valentin BoudoNouna Health Research Center, Nouna, Burkina Faso.
Christabel JamesUniversity of Ibadan Research Foundation, Ibadan, Nigeria.
Dongqing WangDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, United States of America.
Frank MapendoAfrica Academy for Public Health, Dar es Salaam, Tanzania.ORCID https://orcid.org/0000-0002-0067-7113
Ourohiré MillogoNouna Health Research Center, Nouna, Burkina Faso.
Nega AssefaCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Angela ChukwuDepartment of Statistics, University of Ibadan, Ibadan, Nigeria.
Firehiwot WorknehAddis Continental Institute of Public Health, Addis Ababa, Ethiopia.
Bruno LankoandeInstitut Supérieur des Sciences de la Population, University of Ouagadougou, Ouagadougou, Burkina Faso.
Elena C HemlerDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, United States of America.
Abbas IsmailCollege of Natural and Mathematical Sciences, University of Dodoma, Dodoma, Tanzania.
Sulemana AbubakariKintampo Health Research Center, Research and Development Division, Ghana Health Service, Kintampo, Ghana.ORCID https://orcid.org/0000-0002-3448-9938
Kwaku Poku AsanteKintampo Health Research Center, Research and Development Division, Ghana Health Service, Kintampo, Ghana.
Yemane BerhaneAddis Continental Institute of Public Health, Addis Ababa, Ethiopia.
Japhet KillewoAfrica Academy for Public Health, Dar es Salaam, Tanzania.
Ayoade OduolaUniversity of Ibadan Research Foundation, Ibadan, Nigeria.
Ali SieNouna Health Research Center, Nouna, Burkina Faso.
Abdramane SouraInstitut Supérieur des Sciences de la Population, University of Ouagadougou, Ouagadougou, Burkina Faso.
Mary Mwanyika-SandoAfrica Academy for Public Health, Dar es Salaam, Tanzania.
Said VuaiCollege of Natural and Mathematical Sciences, University of Dodoma, Dodoma, Tanzania.
Emily SmithDepartment of Global Health, Milken Institute School of Public Health, George Washington University, Washington, DC, United States of America.
Till BaernighausenHeidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.
Raji TajudeenDivision of Public Health Institutes and Research, Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.ORCID https://orcid.org/0000-0001-9849-5088
Wafaie W FawziDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The African continent has some of the world's lowest COVID-19 vaccination rates. While the limited availability of vaccines is a contributing factor, COVID-19 vaccine hesitancy among healthcare providers (HCP) is another factor that could adversely affect efforts to control infections on the continent. We sought to understand the extent of COVID-19 vaccine hesitancy among HCP, and its contributing factors in Africa. We evaluated COVID-19 vaccine hesitancy among 1,499 HCP enrolled in a cross-sectional study conducted as a telephone survey in Burkina Faso, Ethiopia, Nigeria, Tanzania, and Ghana between July to December of 2021. We defined COVID-19 vaccine hesitancy among HCP as self-reported responses of definitely not, maybe, unsure, or undecided on whether to get the COVID-19 vaccine, compared to definitely getting the vaccine. We used log-binomial or modified Poisson regression models to evaluate factors influencing vaccine hesitancy among HCP. Approximately 65.6% of the HCP interviewed were nurses and the mean age (±SD) of participants was 35.8 (±9.7) years. At least 67% of the HCP reported being vaccinated. COVID-19 vaccine hesitancy affected 45.7% of the HCP in Burkina Faso, 25.7% in Tanzania, 9.8% in Ethiopia, 9% in Ghana and 8.1% in Nigeria. Among unvaccinated HCP reasons for low vaccine uptake included concern about vaccine effectiveness, side effects, and fear of receiving experimental and unsafe vaccines. HCP reporting that COVID-19 vaccines are very effective (RR: 0.21, 95% CI: 0.08, 0.55), and older HCP (45 or older vs.20-29 years, RR: 0.65, 95% CI: 0.44, 0.95) were less likely to be vaccine-hesitant. Nurses were more likely to be vaccine-hesitant (RR 1.38, 95% CI: 1.01, 1.89) than doctors. Information asymmetry among HCP, beliefs about vaccine effectiveness, and the endorsement of vaccines by public health institutions may be important. Efforts to address hesitancy should consider information and knowledge gaps among different cadres of HCP alongside efforts to increase vaccine supply.

Identifiers

PMID39982973
PMCPMC11844854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.